Thursday, November 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 2, 2026

Aptiv (APTV) Q4 2025 Earnings Call Transcript

View original at finance.yahoo.com
“Lastly, we generated $818 million of operating cash flow, more than half of which we deployed towards share repurchases and debt reduction. Varun will discuss each of these in more detail a bit later.”
Verbatim excerpt from the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Total bookings for 2026 expected to exceed $30B for combined Aptiv and Versagen

    80% confidence
  • Historical DRAM cost recovery has been approximately 100% pass-through to customers

    80% confidence
  • Software and services business represents approximately 25% of NuAptiv business with mid-teens growth rate

    80% confidence
  • Aptiv is highly confident it will be able to push DRAM cost increases through to OEM customers

    80% confidence
  • Versagen has momentum heading into 2026 and is confident in ability to deliver shareholder value as independent company

    80% confidence
  • Non-automotive revenue grew 8% full-year 2025, with other industrial growing faster than commercial vehicles in Q4

    80% confidence
  • 2026 vehicle production forecast revised to down 1% from prior expectation of up 1%, with Q1 down 4%

    80% confidence
  • 2026 is a very exciting year for both Aptiv and for Versagen as we unlock value through the formation of two independent, optimally positioned public companies

    80% confidence
  • The four to seven points growth target through 2028 remains intact

    80% confidence
  • Our resilient operating model enables us to execute flawlessly in this dynamic environment

    80% confidence
  • China weakness expected in Q1 2026 with strengthening expected Q3-Q4

    80% confidence
  • DRAM price increases expected to be low double-digits in 2026, with 2027 expected to be less than 100-120% increases

    80% confidence
  • Supply chain visibility achieved at 95% to Tier 3 and 99% for semiconductors to Tier 5

    80% confidence
  • Copper budgeted at $5.50/lb for 2026 versus $4.51 actual in 2025, representing approximately $200M top-line revenue impact for Versagen

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com